改良头颈吞咽量表:利用EORTC-QLQ-H&N35预测总生存
本研究为单中心回顾性队列研究,基于736例头颈癌患者中328例的数据,利用EORTC-QLQ-H&N35构建的改良头颈吞咽量表(m-HNSW)评估吞咽困难,发现治疗结束后3、6、12个月的m-HNSW评分与总生存显著相关。
要点
- m-HNSW基于EORTC-QLQ-H&N35的3个问题构成9分制吞咽困难量表。
- 治疗结束后3个月m-HNSW评分与1年(HR=1.24)和5年(HR=1.19)生存显著相关。
- m-HNSW评分每增加1分,治疗后1年和5年死亡风险分别增加24%和19%。
核心结论
- m-HNSW是一种利用已验证的EORTC-QLQ-H&N35数据简单评估吞咽困难的方法,在治疗结束后3、6、12个月评分可预测总生存。
研究设计与样本
- 回顾性单中心队列研究,利用前瞻性收集的高容量三级转诊中心头颈癌患者数据库,识别736例完成治疗超过2年的患者,最终分析包含328例。
- 使用Cox比例风险模型控制人口学、肿瘤分期、部位和治疗因素。
主要发现
- m-HNSW评分每增加1分,治疗后1年和5年死亡风险分别增加24%和19%。
关键数值与推荐
- m-HNSW使用3个问题构成9分制吞咽困难量表。
临床怎么用
- 可利用EORTC-QLQ-H&N35数据计算m-HNSW评分,在治疗结束后3、6、12个月评估吞咽困难并预测总生存。
局限性
- 回顾性研究,证据等级为4级。
- 单中心研究,最终分析仅纳入328例患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Dysphagia is a treatment-related complication of head and neck cancer (HNCA). We demonstrate the predictive value of a modified head and neck swallow scale (m-HNSW) adapted from the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Head and Neck 35 (EORTC-QLQ-H&N35). STUDY DESIGN: Retrospective Cohort Study. METHODS: Retrospective, single-center cohort study utilizing a prospectively collected database of HNCA patients in a high-volume tertiary referral center. 736 HNCA patients more than 2 years from completion of treatment were identified. EORTC-QLQ-H&N35 data collected from at least one of three defined episodes of care were used. The m-HNSW uses three questions to form a 9-point dysphagia scale. A Cox proportional hazards model was used to determine the effect of the m-HNSW while controlling for demographics, tumor staging, site, and treatment. RESULTS: Using data from 3, 6, 12 months from treatment, we analyzed a subset that included 328 patients. Three months after the completion of therapy, the m-HNSW score had a significant association with 1 (HR = 1.24, P = .0005) and 5 year survival (HR = 1.19, P = .0002) after accounting for body mass index. Six (HR = 1.14, P = .014) and 12 month (hazard ratio (HR) = 1.33, P < .0001) scores post completion of therapy predict 5-year survival. An increase of the m-HNSW score by 1 point was associated with an increase in death by 24%, and 19% at 1 and 5 years following therapy. CONCLUSIONS: The m-HNSW is a simple assessment of dysphagia using previously validated EORTC-QLC-H&N35 data that when taken at 3, 6, and 12 months after completion of therapy is predictive of overall survival. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:2478-2482, 2021.
引用
- von Allmen D, Tang A, Takiar V, et al. Modified Head and Neck Swallow Scale: Using EORTC-QLQ-H&N35 to Predict Overall Survival. Laryngoscope. 2021. PMID: 33894000. doi:10.1002/lary.29559
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。